Promoting demand-side innovation: prizes for payers
From the paper:
Promoting Healthcare Innovation on the Demand Side,1 the recent article by Professors Rebecca Eisenberg and Nicholson Price, is a thoughtful, detailed look at an issue that has gone almost entirely unexplored in the innovation policy literature. Eisenberg & Price focus on what they refer to as ‘demand-side innovation’, considering the ways in which health insurers can contribute to the development of new knowledge about health care technologies.2 The literature has typically portrayed insurers as simply payers, and although some recent scholarship has considered the ways in which choices about which drugs or devices to pay for affect innovation incentives on the front end,3 Eisenberg & Price are the first to delve into the active role that payers themselves can play in the innovation process.
Read more here!bioethics fda health care finance health care reform health law policy pharmaceuticals rachel sachs regulation